XNCR earnings: real EPS beat/miss history, analyst consensus Buy, P/E -8.52. Updated 2026-07-23.
Xencor (XNCR) Research Hub
Xencor (XNCR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 24.41 USD (-2.13%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.52, market cap 1.42B. This hub links to the full technical, earnings and options research available for XNCR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 24.41 USD (-2.13%) |
| 52-week range | 11.99 USD – 30.61 USD |
| Trend regime | Range |
| 14-day RSI | 60.5 (Bullish) |
| Trailing P/E | -8.52 |
| Market cap | 1.42B |
| Dividend yield | 0.00% |
Available research for XNCR
Covered Call on XNCR: how it works, illustrative setup around the real 24.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on XNCR: how it works, illustrative setup around the real 24.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on XNCR: how it works, illustrative setup around the real 24.41 USD price, max profit/loss, breakeven and when to use it. Educational.
XNCR technical analysis: range, last 24.41 USD, RSI 60.5, 52w range 11.99 USD–30.61 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is XNCR in?
Xencor (XNCR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is XNCR in an uptrend or downtrend?
As of 2026-09-11, XNCR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is XNCR's trailing P/E ratio?
XNCR's trailing P/E is -8.52, with a market cap of 1.42B. See the earnings research page for full valuation detail.